Skip to content

Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations

Feasibility of Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for the Treatment of Venous Malformations.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04486599
Acronym
SCLERONAV
Enrollment
30
Registered
2020-07-24
Start date
2020-07-15
Completion date
2022-05-12
Last updated
2023-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Malformation

Keywords

Foam Sclerotherapy, Ultrasound, Electromagnetic Navigation

Brief summary

The aim of this study is to evaluate the feasibility of assisted electromagnetic navigation in percutaneous echo-guided sclerotherapy of slow-flow vascular malformations. Feasibility will be defined in terms of the percentage of patients for whom the procedure is successful.

Detailed description

Primary interventional treatment of low flow vascular anomalies includes ultrasound guided foam sclerotherapy. Each procedure involves a percutaneous needle insertion. However, procedures remain complicated to obtain the right trajectory in order to inject the foam at the center of the abnormality. Electromagnetic navigation system tracks the operator's needle, meaning the position and progression of the needle is visualized in 3D real time on the ultrasound probe interface. The present trial evaluate the feasibility of the electromagnetic navigation system during the needle insertion and the improvement of needle placement accuracy.

Interventions

The echo-guided sclerotherapy procedure, assisted by electromagnetic navigation, will be carried out in a clean room during the day hospitalisation and followed by a control Echo-Doppler carried out 2 hours after the procedure.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low Flow Vascular Abnormality diagnosed by Duplex Ultrasound and MRI * Decision of Ultrasound Guided Percutaneous Foam Sclerotherapy taken in multidisciplinary staff meeting

Exclusion criteria

* patients with pacemakers or internal defibrillator * patients with ferromagnetic implanted material * patients who are wards of court or under guardianship * patients deprived of freedom by judicial or administrative decision * patients under legal protection * pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients for whom the procedure is successfulday 1Success of procedure a.e. obtention of venous flow at the extremity of the needle permitting the realization of the foam sclerotherapy treatment.

Secondary

MeasureTime frameDescription
Estimate the number of punctures required to achieve catheterization of the malformation.day 1Number of percutaneous punctures needed to obtain vascular backflow.
Estimate the time to complete catheterization of the malformationday 1Duration of the procedure.
Estimate the undesirable effects associated with assisted electromagnetic navigation.day 1Adverse effects of Electro-Magnetic Navigation.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026